Follow-up on lifestyle changes during pregnancy and their effects on teenagers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study is a follow-up to the original 'Lifestyle in Pregnancy' trial, which involved pregnant women with obesity. It aims to assess the long-term effects of lifestyle interventions, such as dietary advice and physical activity, on both the mothers and their 14-year-old children. The study will invite 301 mothers and their offspring who completed the initial trial for a comprehensive examination to identify modifiable risk factors for childhood obesity. The goal is to understand how interventions during pregnancy can influence health outcomes across generations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Mothers in the initial LiP study selected at the baseline study in 2007-2010
* Teenagers of mothers in the initial LiP study

Exclusion Criteria:

• None

Where it's running

• Steno Diabetes Center Odense
  Odense, Denmark Recruiting

Study contacts

• Principal investigator: Christina A Vinter, M.D. Ph.D. — Department of Gynecology and Obstetrics. Odense University Hospital. University of Southern Denmark
• Study coordinator: Christina A. Vinter, M.D. Ph.D.
• Email: Christina.vinter@rsyd.dk
• Phone: +45 21782118

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.